MedTrace Logo

Efficacy of iOWH032 in Dehydrating Cholera

NCT02111304 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2014-09-26

No results posted yet for this study

Summary

The primary hypothesis is that administration of iOWH032 to adult and pediatric males and females with acute cholera due to V. cholerae O1 reduces stool output in the first 24 hours significantly more than does the current standard of care.

Conditions

  • Secretory Diarrhea

Interventions

DRUG

iOWH032

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • PATH

    lead OTHER

Principal Investigators

  • Wasif A Khan, MBBS/MHS · International Centre for Diarrhoeal Disease Research, Bangladesh

  • KATM Ehsanul Huq, MBBS/DTM · International Centre for Diarrhoeal Disease Research, Bangladesh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-01-31
Completion
2016-05-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02111304 on ClinicalTrials.gov